Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[A chronic problem-the chronic headache patient].

A Straube1

  • 1Neurologische Klinik, Klinikum Grosshadern der Universität München. astraube@nefo.med.uni-muenchen.de

Schmerz (Berlin, Germany)
|July 13, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A general model for the motion of multivalent cargo interacting with substrates.

Journal of the Royal Society, Interface·2023
Same author

Migraine patients in Germany - need for medical recognition and new preventive treatments: results from the PANORAMA survey.

The journal of headache and pain·2021
Same author

[Trigeminal neuralgia: treatment options for refractory cases].

MMW Fortschritte der Medizin·2019
Same author

[Headache again].

MMW Fortschritte der Medizin·2018
Same author

[Treatment of chronic migraine with botulinum neurotoxin A : Expert recommendations of the German Migraine and Headache Society].

Der Nervenarzt·2018
Same author

[Modern non-cosmetic treatment with botulinum toxins].

Der Internist·2017

Chronic daily headache, affecting 3-5% of people, now requires differentiating various types like chronic migraine. Treatment involves drug withdrawal and preventive therapies for better outcomes.

Area of Science:

  • Neurology
  • Epidemiology

Context:

  • Chronic daily headache affects 3-5% of the population.
  • The International Headache Society (IHS) classification now distinguishes various chronic headache types beyond chronic tension-type headache.

Purpose:

  • To highlight the diagnostic shift in chronic headache classification.
  • To emphasize the importance of differentiating chronic migraine and medication overuse headache.
  • To outline therapeutic consequences of the new classification.

Summary:

  • Chronic daily headache diagnosis now involves differentiating subtypes like chronic migraine and medication overuse headache, which constitute over 60% of cases.
  • The updated classification necessitates drug withdrawal and initiating migraine preventive therapy.
  • Multimodal therapy, including education, behavioral, and pharmacological approaches, shows promise for chronic pain management.

Related Experiment Videos

Impact:

  • Improved diagnostic accuracy for chronic daily headache.
  • Enhanced therapeutic strategies for chronic migraine and medication overuse headache.
  • Promotes a comprehensive, multimodal approach to managing chronic headache syndromes.